| NCT Number | NCT06908629 |
| Lead Sponsor | Barbara Ann Karmanos Cancer Institute |
| Conditions | Cancer, Cancer Survivors, Gastrointestinal Cancers, Neuroendocrine Tumors, Multiple Myeloma, Neoplasms |
| Enrollment | 120 participants |
| Start Date | 2024-09-03 |
| Primary Completion | 2027-05 (estimated) |
| Study Completion | 2027-05 (estimated) |
| Updated on ClinicalTrials.gov | 2025-08-26 |